These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1814746)

  • 21. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E; Kobelinsky M; Khoury R; Sarkis P; Bouyer I; Dauphin A; Delmas V; Boccon-Gibod L
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile dysfunction: intracavernous treatment.
    Ledda A
    Curr Med Res Opin; 2000; 16 Suppl 1():s59-62. PubMed ID: 11329824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine.
    Rodrigues M; Granegger S; O'Grady J; Sinzinger H; Stackl W
    Adv Exp Med Biol; 1997; 433():79-82. PubMed ID: 9561108
    [No Abstract]   [Full Text] [Related]  

  • 26. Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1.
    Meuleman EJ; Bemelmans BL; Doesburg WH; van Asten WN; Skotnicki SH; Debruyne FM
    J Urol; 1992 Jul; 148(1):63-6. PubMed ID: 1613884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cyclic adenosine monophosphate in prostaglandin E1-induced penile erection in rabbits.
    Lin JS; Lin YM; Jou YC; Cheng JT
    Eur Urol; 1995; 28(3):259-65. PubMed ID: 8536783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction].
    Jantos C; Krause W; Kauss E; Weidner W
    Urologe A; 1988 Jan; 27(1):18-21. PubMed ID: 3363769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1.
    Seyam R; Mohamed K; Akhras AA; Rashwan H
    Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
    Floth A; Schramek P
    J Urol; 1991 Jan; 145(1):56-9. PubMed ID: 1984099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms.
    Escrig A; Marin R; Mas M
    J Urol; 1999 Dec; 162(6):2205-10. PubMed ID: 10569620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M; Schramek P
    J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B; Donatucci CF; Kaula N; Lue TF
    J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of penile erection by intracavernosal injection: a double-blind comparison of phenoxybenzamine versus papaverine-phentolamine versus saline.
    Szasz G; Stevenson RW; Lee L; Sanders HD
    Arch Sex Behav; 1987 Oct; 16(5):371-8. PubMed ID: 3689105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.